Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia
European Journal of Therapeutics · 29.01.2024 · 30 (3) · 354-361
DOI: 10.58600/eurjther1976 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Therapeutics, online erschienen am 29.01.2024. Verfasst von Mihrican Yeşildağ und 3 weiteren Autor:innen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Objective
Biomarkers in community-acquired pneumonia (CAP) have the potential to facilitate clinical decisions by guiding the prediction of disease severity, treatment and prognosis. In this study, we evaluated the relationship of biomarkers with disease severity in patients with CAP.
Methods
156 patients diagnosed with CAP were included in the study. Diagnosis of CAP was determined according to the Infectious Diseases Society of America (IDSA)/ American Thoracic Society(ATS) 2019 guidelines along with clinical findings. The CRB-65 scoring system was used to determine outpatient and hospitalized patients. Patient information was obtained retrospectively from their files. In these two patient groups; C-reactive protein (CRP), complete blood count (CBC) parameters, neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), monocyte/neutrophil ratio (MNR), lymphocyte/monocyte ratio (LMN), lymphocyte/CRP ratio (LCR), WBC/mean platelet volume ratio (WBC/MPV), CRP/MPV ratio, and MPV/PLT ratio were examined.
Results
Of the 156 patients included in the study, 72 were pneumonia patients receiving inpatient treatment (mean age 66.88±16.29) and 84 patients receiving outpatient treatment (mean age 51.57±16.68). Age was found to be statistically significant between the groups (p< 0.001). In the inpatient group; CRP, WBC, neutrophil, lymphocyte, monocyte, basophil, hemoglobin, hematocrit, MPV, NLR, PLR, LMR, NMR, LMR, LCR, WBC/MPV, and CRP/MPV were found to be significantly high (p
Zitieren
APA
Yeşildağ, M., Bakdık, B. Ö., Balasar, B., & Eroğlu, E. (2024). Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia. European Journal of Therapeutics, 30(3), 354-361. https://doi.org/10.58600/eurjther1976
Vancouver
Yeşildağ M, Bakdık BÖ, Balasar B, Eroğlu E. Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia. European Journal of Therapeutics. 2024;30(3):354-361. doi:10.58600/eurjther1976
BibTeX
@article{Yeilda2024,
author = {Yeşildağ, Mihrican and Bakdık, Bengü Özkan and Balasar, Barış and Eroğlu, Esma},
title = {Evaluation of the Relationship Between Biomarkers and Disease Severity in Patients with Community-Acquired Pneumonia},
journal = {European Journal of Therapeutics},
year = {2024},
volume = {30},
number = {3},
pages = {354--361},
doi = {10.58600/eurjther1976}
}
EUVIMED